Conference Sponsor

Commitment to Research, Development and Innovation:

• Prolacta Bioscience is a privately-held life sciences company dedicated to Advancing the Science of Human Milk.® The company was founded in 1999 and has invested more than $40 million in research and development, clinical studies and world-class manufacturing facilities for its Neonatal Nutritional Products.
• Prolacta's flagship commercial product, a Human Milk Fortifier (HMF) made exclusively with 100% donor breast milk, became available to hospitals for use and by prescription in the Neonatal Intensive Care Unit (NICU) in 2005
• Today, Prolacta is the world leader in providing donor breast milk products to hospitals. Prolacta develops clinically proven, high-quality products derived from human milk that are designed to meet the needs of extremely premature infants in the NICU.
• Prolacta’s Neonatal Nutritional Products are clinically proven to improve health outcomes, decrease mortality and reduce healthcare system costs for critically ill preemies in the NICU.
• To further advance the science in human milk, Prolacta founded the International Conference on Human Milk Science and Innovation, a forum covering the latest in scientific and clinical research related to human milk. Renowned scientists and clinicians from around the world attend this annual event.